Medicine
Chlordiazepoxide and Clidinium 5 mg/2.5 mg capsule
Chlordiazepoxide and Clidinium 5 mg/2.5 mg capsule is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Key facts
- Active ingredient (INN)
- Chlordiazepoxide and Clidinium
- Brand
- Sold under the generic name
- Strength
- 5 mg/2.5 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 1000 capsules, 500 capsules and 18 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaMicro LabsIndiaBryant Ranch PrepackAmerican Health PackagingAmneal Pharmaceuticals NYChartwell RXMisemer PharmaceuticalsSunrise Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 July 2020
- Identifiers
- RxCUI 889614DailyMed set ID ec7733c5-3aad-496a-8007-5d7596ede630, 398931c6-4954-4bbc-8b63-ea382e5864fc, 160c6524-314f-404a-ac04-0f3bfae2fde3 +14NDC 72162-2436, 46708-744, 72162-1237 +14Application ANDA215835, ANDA216969, ANDA211421 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 46708-744-31 | Alembic PharmaceuticalsIndia | 4 October 2023 |
| 1000 capsule in 1 bottle | 46708-744-91 | Alembic PharmaceuticalsIndia | 4 October 2023 |
| 100 capsule in 1 bottle | 62332-744-31 | Alembic PharmaceuticalsIndia | 4 October 2023 |
| 1000 capsule in 1 bottle | 62332-744-91 | Alembic PharmaceuticalsIndia | 4 October 2023 |
| 100 capsule in 1 bottle | 67877-731-01 | Ascend LaboratoriesIndia | 27 April 2021 |
| 500 capsule in 1 bottle | 67877-731-05 | Ascend LaboratoriesIndia | 27 April 2021 |
| 100 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-731-38 | Ascend LaboratoriesIndia | 27 April 2021 |
| 100 capsule in 1 bottle | 59651-524-01 | Aurobindo PharmaIndia | 14 September 2023 |
| 100 capsule in 1 bottle | 42571-381-01 | Micro LabsIndia | 1 October 2022 |
| 100 capsule in 1 bottle, plastic | 60219-1677-1 | Amneal Pharmaceuticals NY | 25 October 2021 |
| 120 capsule in 1 bottle | 62135-696-12 | Chartwell RX | 8 June 2022 |
| 100 capsule in 1 bottle | 0276-0500-10 | Misemer Pharmaceuticals | 3 September 2020 |
| 100 capsule in 1 bottle | 11534-197-01 | Sunrise Pharmaceutical | 9 July 2020 |
| 100 capsule in 1 bottle, plastic | 75826-134-10 | Winder Laboratories | 7 December 2020 |
| 100 capsule in 1 bottle | 63629-2373-1 | Bryant Ranch Prepack | 24 June 2022 |
| 100 capsule in 1 bottle | 63629-8859-1 | Bryant Ranch Prepack | 27 April 2021 |
| 100 capsule in 1 bottle | 71335-2966-1 | Bryant Ranch Prepack | 8 January 2026 |
| 100 capsule in 1 bottle | 71335-9764-1 | Bryant Ranch Prepack | 15 August 2023 |
| 100 capsule in 1 bottle | 72162-1237-1 | Bryant Ranch Prepack | 5 December 2023 |
| 100 capsule in 1 bottle | 72162-2436-1 | Bryant Ranch Prepack | 13 February 2025 |
| 20 blister pack in 1 carton / 1 capsule in 1 blister pack | 60687-639-94 | American Health Packaging | 6 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 1 September 1966 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Chlordiazepoxide and Clidinium 5 mg/2.5 mg capsule.
Clinical summary
Chlordiazepoxide and Clidinium is a fixed-dose combination of an anticholinergic and a benzodiazepine indicated to control emotional and somatic factors in gastrointestinal disorders. It is available as capsules for oral use. MedsAcross supplies Chlordiazepoxide and Clidinium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Chlordiazepoxide and ClidiniumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Librax prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Chlordiazepoxide and Clidinium 5 mg/2.5 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.